Fundraising Fox

Turnstone Biologics

New York, US · Founded 2018 · Delaware corporation · 7 known investors

Biotech

Founders & leadership

MB
Michael BurgessExecutive
JM
Jose Manuel OteroNamed on SEC filing
RG
Robert GouldNamed on SEC filing
JH
Jane HendersonNamed on SEC filing
SL
Stefan LarsonNamed on SEC filing
PM
Patrick MachadoNamed on SEC filing
SF
Sammy FarahNamed on SEC filing

Board

BBBrad Bolzon
Brad BolzonBoard directorChairman, Managing Director at Versant Ventures
JDJerel Davis
Jerel Davisin𝕏Board directorManaging Director at Versant Ventures
RG
Rishi GuptainBoard directorPartner at OrbiMed

Investors · 7

Brace PharmaAtlanta
F-Prime CapitalCambridge · $3M – $10M
FACIT (Fight Against Cancer Innovation Trust)Toronto · $1.1M
Foothill VenturesLos Altos · $100K – $10M
Venture OntarioToronto
OrbiMedreportedNew York · $1M – $75M
Versant VenturesreportedSan Francisco · $250K – $5Mvia Brad Bolzon · board

Reported raises · per SEC filings

Form D private placements

$122.1M disclosed across 2 rounds · 2019–2021

▶$80MraisedJul 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick MachadoDirector
  • Maura CampbellExecutive Officer
  • Stefan LarsonDirector
  • Robert GouldDirector
  • Jose Manuel OteroExecutive Officer
  • Jerel DavisDirector
  • Michael BurgessExecutive Officer, Director
  • Sammy FarahExecutive Officer, Director
  • Rishi GuptaDirector
Offering amount
$80M
Amount sold
$80M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.1MraisedJan 2019 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad BolzonDirector
  • Jose Manuel OteroExecutive Officer
  • Robert GouldDirector
  • Jerel DavisDirector
  • Jane HendersonExecutive Officer
  • Michael BurgessExecutive Officer
  • Stefan LarsonDirector
  • Patrick MachadoDirector
  • Rishi GuptaDirector
  • Sammy FarahExecutive Officer, Director
Offering amount
$42.1M
Amount sold
$42.1M
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Turnstone Biologics's investors?
Turnstone Biologics's investors include Brace Pharma, F-Prime Capital, FACIT (Fight Against Cancer Innovation Trust), Foothill Ventures, Venture Ontario, OrbiMed, Versant Ventures.
How much funding has Turnstone Biologics raised?
Turnstone Biologics has disclosed $122.1M raised across 2 rounds.
Where is Turnstone Biologics headquartered?
Turnstone Biologics is headquartered in New York, US.